Treatment of Acute Kidney Injury in Cancer Patients: From Theory to Practice
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 March 2026 | Viewed by 18
Special Issue Editors
Interests: AL amyloidosis; MGRS; immune checkpoint inhibitors; precision medicine
Special Issue Information
Dear Colleagues,
Acute kidney injury (AKI) is a common morbidity among cancer patients, with incidence rates reported as high as 50% in certain populations. AKI may result from complications directly related to the malignancy or as an adverse effect of cancer treatment modalities. Over the past decade, cancer therapy has undergone a profound transformation with the advent of targeted therapies, immunotherapy, and cellular therapies. While AKI was historically associated primarily with conventional chemotherapy, it is now increasingly recognized as a complication of these newer, more sophisticated treatment approaches.
Consequently, the management of AKI in cancer patients has evolved from traditional supportive strategies aimed at preserving renal function to more precise, mechanism-based interventions. With the growing integration of precision medicine in oncology, personalized approaches to AKI management—tailored to the specific clinical and therapeutic context of each patient—are becoming more widely adopted.
Effective treatment of AKI in cancer patients demands a multidisciplinary approach involving oncologists, nephrologists, urologists, interventional radiologists, and pharmacists. In this Special Issue, we aim to highlight the evolving landscape of AKI management in patients with both solid tumors and hematologic malignancies, with particular emphasis on kidney injury associated with emerging therapies such as targeted agents, immune checkpoint inhibitors, CAR T-cell therapies, bispecific antibodies (BiTEs), and others.
Dr. Umut Selamet
Dr. Shveta S. Motwani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immune check point inhibitor related nephritis
- MGRS
- CART cell therapy
- stem cell transplant
- TMA
- BK nephropathy
- cisplatin nephropathy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
